Evidence map›Paper›PMID 29734337›Full record

ArticlePLoS neglected tropical diseases2018

Highly targeted cholera vaccination campaigns in urban setting are feasible: The experience in Kalemie, Democratic Republic of Congo.

Louis Albert Massing, Soumah Aboubakar, Alexandre Blake, Anne-Laure Page, Sandra Cohuet, Adalbert Ngandwe, Eric Mukomena Sompwe, Romain Ramazani, Marcela Allheimen, Philippe Levaillant and 10 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Impact of a multi-pronged cholera intervention in an endemic setting.medRxiv : the preprint server for health sciences · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 2 countries.

Louis Albert MassingMédecins Sans Frontières, Katanga, Democratic Republic of Congo.
Soumah AboubakarEpicentre, Paris, France.
Alexandre BlakeEpicentre, Paris, France.ORCID 0000-0002-1627-4992
Anne-Laure PageEpicentre, Paris, France.
Sandra CohuetEpicentre, Paris, France.
Adalbert NgandweMinistère de la Santé Publique, Katanga, Democratic Republic of Congo.
Eric Mukomena SompweMinistère de la Santé Publique, Katanga, Democratic Republic of Congo.
Romain RamazaniMédecins Sans Frontières, Katanga, Democratic Republic of Congo.
Marcela AllheimenMédecins Sans Frontières, Paris, France.
Philippe LevaillantMédecins Sans Frontières, Paris, France.
Pauline LechevalierMédecins Sans Frontières, Paris, France.
Marie KashimiMédecins Sans Frontières, Katanga, Democratic Republic of Congo.
Axelle de la MotteMédecins Sans Frontières, Paris, France.
Arielle CalmejaneMédecins Sans Frontières, Paris, France.
Malika BouheniaEpicentre, Paris, France.
Ernest DabireWorld Health Organization, Kinshasa, Democratic Republic of Congo.
Didier BompangueMinistère de la Santé Publique, Kinshasa, Democratic Republic of Congo.
Benoit KebelaMinistère de la Santé Publique, Kinshasa, Democratic Republic of Congo.
Klaudia PortenEpicentre, Paris, France.
Francisco LuqueroEpicentre, Paris, France.ORCID 0000-0003-0885-8418
Médecins Sans Frontières · FRMinistry of Public Health · CD

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionOral cholera vaccines are primarily recommended by the World Health Organization for cholera control in endemic countries. However, the number of cholera vaccines currently produced is very limited and examples of OCV use in endemic countries, and especially in urban settings, are scarce. A vaccination campaign was organized by Médecins Sans Frontières and the Ministry of Health in a highly endemic area in the Democratic Republic of Congo. This study aims to describe the vaccine coverage achieved with this highly targeted vaccination campaign and the acceptability among the vaccinated communities. METHODS AND

findingsWe performed a cross-sectional survey using random spatial sampling. The study population included individuals one year old and above, eligible for vaccination, and residing in the areas targeted for vaccination in the city of Kalemie. Data sources were household interviews with verification by vaccination card. In total 2,488 people were included in the survey. Overall, 81.9% (95%CI: 77.9-85.3) of the target population received at least one dose of vaccine. The vaccine coverage with two doses was 67.2% (95%CI: 61.9-72.0) among the target population. The vaccine coverage was higher during the first round (74.0, 95%CI: 69.3-78.3) than during the second round of vaccination (69.1%, 95%CI: 63.9-74.0). Vaccination coverage was lower in male adults. The main reason for non-vaccination was to be absent during the campaign. No severe adverse events were notified during the interviews.

conclusionsCholera vaccination campaigns using highly targeted strategies are feasible in urban settings. High vaccination coverage can be obtained using door to door vaccination. However, alternative strategies should be considered to reach non-vaccinated populations like male adults and also in order to improve the efficiency of the interventions.

Indexed as

AdolescentChildChild, PreschoolCholeraCholera VaccinesCross-Sectional StudiesDemocratic Republic of the CongoFemaleHumansInfantMaleVaccinationCholera Vaccines

Identifiers

PMID29734337
PMCPMC5957443
OpenAlexW2801306537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.